e-Drug3D

918

DAPTOMYCIN


INN
DAPTOMYCIN

cas 103060-53-3
CLASS

ANTIINFECTIVES
ANTI-BACTERIAL AGENTS
GRAM POSITIVE BACTERIA

ROUTE (list)

INTRAVENOUS

ATC code

J01XX09

PK parameters

VD 6.3 LITER (65 KILOGRAM)
Cl 0.58 LITER / HOUR (65 KILOGRAM)
PPB 92 PERCENT
t1/2 7.7 HOUR

Target

TARGET MEMBRANE

DrugCentral

Unknown

Download SDF file (3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-9-(hydroxymethyl)-6-(4-hydroxy-4-oxobutan-2-yl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid

Formula:
C72H101N17O26

Calculated chemical properties:

MW 1616.67
NB_atoms 115
XLogP -10.96
PSA 622.154
NB_HD 21
NB_HA 43
fsp3 0.53
Lipinski(0=no;1=yes) 0

FDA
NDA 021572 (pdf not found) INN (DAPTOMYCIN) CUBICIN (CUBIST PHARMS LLC) APPROVAL= AP YEAR= 2003 DISCONTINUED
NDA 203797 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HOSPIRA INC) APPROVAL= TA YEAR= 2013
NDA 202857 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HOSPIRA) APPROVAL= AP YEAR= 2014 DISCONTINUED
NDA 091039 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (TEVA PHARMS USA) APPROVAL= AP YEAR= 2016
NDA 206005 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (XELLIA PHARMS APS) APPROVAL= AP YEAR= 2016
NDA 208385 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2017
NDA 209949 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HIKMA) APPROVAL= AP YEAR= 2017
NDA 206077 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2018
NDA 205037 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (MYLAN LABS LTD) APPROVAL= AP YEAR= 2018
NDA 208375 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (DR REDDYS) APPROVAL= AP YEAR= 2019
NDA 207104 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2019
NDA 211961 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2019
NDA 212022 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HENGRUI PHARMA) APPROVAL= AP YEAR= 2019
NDA 212513 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (BE PHARMS) APPROVAL= AP YEAR= 2019
NDA 212667 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2019
NDA 211403 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (DR REDDYS) APPROVAL= AP YEAR= 2020
NDA 213425 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (BE PHARMS) APPROVAL= AP YEAR= 2020
NDA 210282 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HOSPIRA) APPROVAL= AP YEAR= 2021
NDA 212250 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HISUN PHARM HANGZHOU) APPROVAL= AP YEAR= 2021
NDA 213623 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (MEITHEAL) APPROVAL= AP YEAR= 2021
NDA 213786 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (MEITHEAL) APPROVAL= AP YEAR= 2021
NDA 213171 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (EUGIA PHARMA) APPROVAL= AP YEAR= 2021
NDA 215215 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HANGZHOU ZHONGMEI) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 215316 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (QILU PHARM HAINAN) APPROVAL= AP YEAR= 2021
NDA 213645 (pdf not found) INN (DAPTOMYCIN) DAPZURA RT (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2022
NDA 215890 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HAINAN POLY PHARM) APPROVAL= AP YEAR= 2022
NDA 216413 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (ASPIRO) APPROVAL= AP YEAR= 2022
NDA 216445 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (ASPIRO) APPROVAL= AP YEAR= 2022
NDA 217415 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (HIKMA) APPROVAL= AP YEAR= 2023
NDA 213966 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (MYLAN) APPROVAL= AP YEAR= 2023
NDA 213396 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2024 DISCONTINUED
NDA 217215 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (BIOCON PHARMA) APPROVAL= AP YEAR= 2024
NDA 217630 (pdf not found) INN (DAPTOMYCIN) DAPTOMYCIN (MAIA PHARMS INC) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL